You are here: Home Clinical Services Clinical Pathology Mohamed E. Salama, M.D.
Document Actions

Mohamed E. Salama, M.D.

last modified 2012-04-27 11:26 — by Leita Rogers

Associate Professor

Assistant Medical Director of Hematopathology

Director of Hematopathology Fellowship Training Program

Scholarly Emphasis: Hematopathology
Mohamed E.  Salama, M.D.

Mohamed Salama, M.D.

Contact Info

Email Address: mohamed.salama [[at]] path.utah.edu

Office Phone Number: 801-581-5854

Location: Medical Directors ARUP Laboratories

Research Lab: ARUP Institute for Clinical and Experimental Pathology

Division: Anatomic Pathology

Supporting Staff:   Leita Rogers  

 

Selected Publications

  • Salama ME, Perkins SL, Mariappan MR. Primary bone marrow presentation of Epstein-Barr virus-driven HIV-associated Hodgkin lymphoma. AIDS Read, 2007;17(12):604-5.
  • Salama ME, Parham DM, Perkins SL, Bahler D, Ellison DA. Fatal non-transplant-related Epstein-Barr virus-associated atypical lymphoid proliferations in infants and children: A Clinicopathologic Study. Pediatr Dev Pathol. 2008;11(6):443-9.
  • Salama ME, Mariappan MR, Tripp SR, Perkins SL. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma. Int J Surg Pathol. 2010;18(2):121-8.
  • Ustun C, Jillella AP, Salama ME. Dasatinib induces complete cytogenetic response and loss of F359C in an imatinib resistant chronic myelocytic leukemia patient. Am J Hematol. 2009;84(6):386-7.
  • Salama ME, Lossos IS, Warnke RA, Natkunam Y. Immunoarchitectural patterns in nodal marginal zone B-cell lymphoma: A Study of 51 Cases. AJCP, 2009;132:39-49.
  • Salama ME, Swierczek SI, Hickman K, Wilson A, Prchal JT. Plasma quantitation of JAK2 mutation is not suitable as a clinical test: An Artifact of Storage. Blood, 2009;114(1):223-4.
  • Shi L, Wang S, Zangari M, Xu H, Cao T, Xu C, Wu Y, Xiao F, Liu Y, Yang Y, Salama M, Li G, Tricot G, Zhan F. Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance. OncoTarget. 2010;1(1):22-33.
  • Teman C, Wilson A, Perkins SL, Prchal JT, Salama ME. Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: A Computer-assisted Image Study. Leuk Res, 2010;34(7):871-6.
  • Toydemir R, Rowe L, Hibbard M, Salama ME, Shetty S. Cytogenetic and molecular characterization of double inversion 3 associated with a cryptic BCR-ABL1 rearrangement and additional genetic changes. Cancer Genet Cytogenet, 2010;201(2):81-7.
  • Drakos S, Kfoury AG, Hannomd EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Bristow MR, Renlund DG, Li DY. Impact of mechanical unloading on microvasculature and assoicated central remodeling features of the failing human heart. J Am Coll Cardiol, 2010;56(5):382-91.
  • Patel JL, Shetty S, Salama ME. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder. Am J Dermatopathol, 2011;33(3):e31-6.
  • Alkhatib A, Salama ME, Fedoravicius A, Boynton K, Adler DG. Localized esophageal EBV positive plasmablastic lymphoma. Dig Liver Dis, 2011;43(6):498.
  • Geiersbach K, Salama M, Sennett MD, Shetty S. Multi-hit lymphoma with intermediate features and novel t(3;8)(q27;q24) not involving MYC. Leuk Lymphoma, 2011;52(5):922-9.
  • All Publications: Click Here

Professional Education

  • 1994 Doctor of Medicine and Surgery, Faculty of Medicine, Cairo University
  • 1997 Diploma of Health Care and Hospital management